⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL20960849 | 0.95 | — | — | |
| SCHEMBL360475 | 0.95 | — | — | |
| Hydrochloric Acid SCHEMBL1583871 | 0.91 | — | — | |
| Hydrochloric Acid SCHEMBL1583870 | 0.91 | — | — | |
| Hydrochloric Acid SCHEMBL1583874 | 0.91 | — | — | |
| Hydrochloric Acid SCHEMBL25209646 | 0.84 | — | — | |
| Hydrazine SCHEMBL1663937 | 0.84 | — | — | |
| SCHEMBL23950144 | 0.82 | — | — | |
| SCHEMBL22233771 | 0.82 | — | — | |
| SCHEMBL22233772 | 0.82 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 19 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-114591321-A | Aza-and-cyclic compounds, method for the production thereof and use thereof | 广州费米子科技有限责任公司 | 2022-06-07 | — | — | CN | disclosed |
| CN-114249712-A | Pyrimidinyl derivatives, method for the production thereof and use thereof | 广州费米子科技有限责任公司 | 2022-03-29 | — | — | CN | disclosed |
| EP-3157669-B1 | SEPARATION AND STORAGE OF FLUIDS USING ITQ-55 | EXXONMOBIL RES & ENG CO (US) | 2018-09-26 | — | — | EP | disclosed |
| EP-3157668-B1 | SEPARATION AND STORAGE OF FLUIDS USING ITQ-55 | EXXONMOBIL RES & ENG CO (US) | 2018-06-06 | — | — | EP | disclosed |
| EP-3157869-B1 | MATERIAL ITQ-55 AND METHOD FOR PREPARATION | HIGHER COUNCIL OF SCIENT RESEARCH CSIC (ES) | 2018-05-16 | — | — | EP | disclosed |
| EP-3157668-A1 | SEPARATION AND STORAGE OF FLUIDS USING ITQ-55 | ExxonMobil Research and Engineering Company (US) | 2017-04-26 | — | — | EP | disclosed |
| EP-3157869-A1 | MATERIAL ITQ-55, METHOD FOR PREPARATION AND USE | Higher Council Of Scientific Research (CSIC) (ES) | 2017-04-26 | — | — | EP | disclosed |
| EP-3157673-A1 | SEPARATION AND STORAGE OF FLUIDS USING ITQ-55 | ExxonMobil Research and Engineering Company (US) | 2017-04-26 | — | — | EP | disclosed |
| EP-3157669-A1 | SEPARATION AND STORAGE OF FLUIDS USING ITQ-55 | Exxonmobil Research And Engineering Company (US) | 2017-04-26 | — | — | EP | disclosed |
| US-20120122923-A1 | DUAL MOLECULES CONTAINING A PEROXIDE DERIVATIVE, THEIR SYNTHESIS AND THERAPEUTIC USES | SANOFI-AVENTIS (FR) | 2012-05-17 | — | — | US | disclosed |
| US-20120122923-A1 | DUAL MOLECULES CONTAINING A PEROXIDE DERIVATIVE, THEIR SYNTHESIS AND THERAPEUTIC USES | SANOFI-AVENTIS (FR) | 2012-05-17 | — | — | US | disclosed |
| US-20120122923-A1 | DUAL MOLECULES CONTAINING A PEROXIDE DERIVATIVE, THEIR SYNTHESIS AND THERAPEUTIC USES | SANOFI-AVENTIS (FR) | 2012-05-17 | — | — | US | disclosed |
| CN-101466706-A | Bimolecules comprising peroxide derivatives, their synthesis and therapeutic use | SANOFI AVENTIS (FR) | 2009-06-24 | — | — | CN | disclosed |
| EP-2032561-A2 | DUAL MOLECULES CONTAINING A PEROXIDE DERIVATIVE, THEIR SYNTHESIS AND THERAPEUTIC USES | Sanofi-Aventis (FR) | 2009-03-11 | — | — | EP | disclosed |
| WO-2007144487-A2 | DUAL MOLECULES CONTAINING A PEROXIDE DERIVATIVE, THEIR SYNTHESIS AND THERAPEUTIC USES | SANOFI-AVENTIS (FR) | 2007-12-21 | — | — | WO | disclosed |
| US-6191146-B1 | BACTERICIDES, FUNGICIDES, VIRICIDES | SMITHKLINE BEECHAM CORPORATION | 2001-02-20 | — | — | US | disclosed |
| EP-0866700-A4 | HEMOREGULATORY COMPOUNDS | SMITHKLINE BEECHAM CORP (US) | 1999-04-07 | — | — | EP | disclosed |
| EP-0866700-A1 | HEMOREGULATORY COMPOUNDS | SMITHKLINE BEECHAM CORPORATION (US) | 1998-09-30 | — | — | EP | disclosed |
| WO-1997017958-A1 | HEMOREGULATORY COMPOUNDS | SMITHKLINE BEECHAM CORPORATION (US) | 1997-05-22 | — | — | WO | disclosed |